Platelet Adhesion to Collagen Type III of vWF; Addition of the Recombinant vWFs to Normal Whole Blood
Surface . | Addition . | Anticoagulant . | Coverage as % of Control . |
---|---|---|---|
CoII II | WT | Citrate | 100 |
R543Q | 19 ± 73-150 | ||
R543W | 15 ± 73-150 | ||
CoII III | WT | LMWH | 100 |
R543Q | 50 ± 83-151 | ||
R543W | 73 ± 53-151 | ||
vWF | WT | Citrate | 100 |
R543Q | 102 ± 7 | ||
R543W | 98 ± 3 |
Surface . | Addition . | Anticoagulant . | Coverage as % of Control . |
---|---|---|---|
CoII II | WT | Citrate | 100 |
R543Q | 19 ± 73-150 | ||
R543W | 15 ± 73-150 | ||
CoII III | WT | LMWH | 100 |
R543Q | 50 ± 83-151 | ||
R543W | 73 ± 53-151 | ||
vWF | WT | Citrate | 100 |
R543Q | 102 ± 7 | ||
R543W | 98 ± 3 |
Recombinant vWFs (WT, R543Q, and R543W) were added to citrated or LMWH anticoagulated whole blood at 0.5 μg/mL and perfusion was performed using collagen type III or vWF-coated coverslips. The coverslips were exposed to shear rate 1,600 s−1 for 5 minutes at 37°C. The data are mean ± SEM obtained in three independent experiments each performed in triplicate. The mean platelet coverage on CoII III in citrate for WT is 19%, on CoII III in LMWH is 42.3%, and on vWF 56.7%. The platelet count of the perfusates does not differ more than 10%.
P < .01.
P < .05.